Voyageur Pharmaceuticals Ownership

VM Stock  CAD 0.05  0.01  9.09%   
Voyageur Pharmaceuticals maintains a total of 138.81 Million outstanding shares. Voyageur Pharmaceuticals has 10.21 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
 
Shares in Circulation  
First Issued
2012-03-31
Previous Quarter
132.7 M
Current Value
132.7 M
Avarage Shares Outstanding
49 M
Quarterly Volatility
44.7 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Voyageur Pharmaceuticals in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Voyageur Pharmaceuticals, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividend Paid And Capex Coverage Ratio is likely to drop to 6.20 in 2024. Common Stock Shares Outstanding is likely to climb to about 157.6 M in 2024, despite the fact that Net Loss is likely to grow to (1.8 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Voyageur Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Voyageur Stock Ownership Analysis

The company recorded a loss per share of 0.01. Voyageur Pharmaceuticals last dividend was issued on the 7th of March 2017. The entity had 1:2 split on the 7th of March 2017. Voyageur Minerals Ltd., an exploration stage company, engages in acquiring, exploring, and developing mineral exploration properties. The company also has interests in the Paradox Basin and Lithium King lithium brine projects in Utah. VOYAGEUR MINERALS operates under Industrial Metals Minerals classification in Canada and is traded on TSX Venture Exchange. For more information please call Brent Willis at 587 779 6166 or visit https://voyageurpharmaceuticals.ca.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Voyageur Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Voyageur Stock analysis

When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Please note, there is a significant difference between Voyageur Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Voyageur Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Voyageur Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.